Abstract

BackgroundAcute pancreatitis (AP) is a common disease requiring admissions under surgical and critical care units. The two most common causes are alcohol and gallstones. Coronavirus disease 2019 (COVID-19) pandemic had a significant impact on service delivery and patient management throughout all surgical specialties. In this study, the primary aim was to ascertain the incidence of COVID-19 in acute pancreatitis patients. Secondary objectives were to study aetiology, demographics, severity, 30-day mortality, outcomes and management of acute pancreatitis patients from 1st March, 2020 till 31st August, 2020.MethodsA retrospective observational review of all patients admitted under the General Surgical team was performed. Information regarding demographics, severity of AP (using Glasgow score, Atlanta classification and CT severity index score), ICU admission and organ support, treatment modalities and follow-up data for outcomes was collected based on data collection tool used by COVID-PAN study and results were compared to outcomes results of COVID-PAN study.ResultsForty-three (43) patients were admitted with AP. Only one patient (2.3%) was diagnosed with COVID-19 at the time of pancreatitis. Gallstones were noted to be the most common cause of AP in our population. Mortality was 7% (3 patients). Five patients (11%) needed ITU admission due to organ dysfunction. Three patients (7%) developed ARDS.ConclusionThe overall incidence of COVID-19 in pancreatitis in our population of the study was low. The incidence of COVID-19 during the first wave in Derry/Londonderry area was low and this may explain why the incidence was low in our study as well. Patients with AP in our target population were mostly elderly, one in five had moderate to severe or severe pancreatitis and in 16.3% the aetiology could not be identified. As observed in other centres globally, urgent cholecystectomy for gallstone pancreatitis faced significant delays with no patients being offered index cholecystectomy and only 4 out of 19 patients having undergone interval cholecystectomy within six months of index admission for gallstone pancreatitis in our centre.

Highlights

  • Acute pancreatitis (AP) is characterised by inflammation of pancreas, damage to acinar cells and may be associated with local or systemic complications

  • Information regarding demographics, severity of AP, ICU admission and organ support, treatment modalities and follow-up data for outcomes was collected based on data collection tool used by COVID-PAN study and results were compared to outcomes results of COVID-PAN study

  • Our study focuses on patients presenting with AP during the initial six months of the pandemic to Altnagelvin Area Hospital in Derry/Londonderry, Northern Ireland

Read more

Summary

Introduction

Acute pancreatitis (AP) is characterised by inflammation of pancreas, damage to acinar cells and may be associated with local or systemic complications. It occurs due to obstruction of pancreatic ducts, activation of pancreatic enzymes such as trypsin and autodigestion of the gland with local inflammation [1]. It is a common cause of abdominal pain and admission to General Surgery wards. Some studies have postulated that COVID-19 may enter cells using ACE-2 (angiotensin-converting enzyme-2) receptors. As these receptors are abundantly expressed on pancreatic cells, this organ may be a target organ for the virus [4,5]. The primary aim was to ascertain the incidence of COVID-19 in acute pancreatitis patients. Secondary objectives were to study aetiology, demographics, severity, 30-day mortality, outcomes and management of acute pancreatitis patients from 1st March, 2020 till 31st August, 2020

Objectives
Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call